Sage Therapeutics sponsored trial for Parkinson’s Disease Mild Cognitive Impairment (PD-MCI)

Sage Therapeutics sponsored trial for Parkinson’s Disease Mild...see more Cognitive Impairment (PD-MCI): Research study for adults ages 50 to 75 years old who have been diagnosed with PD-MCI. The purpose of this study is to evaluate the safety and tolerability of an investigational medication. Participants must […]

Read More